Focus on Equities that offer Growth,
Value and Strong Potential Return
Monday, July 28, 2014

Sarepta Therapeutics, Inc.

In-Depth Research Report Available for SRPT

Download Free Report Now

Company Profile SRPT

Sarepta Therapeutics shares increased 4.53 percent to close at $32.55 a share Thursday. The stock traded between $31.89 and $33.74 on volume of 1.60 million shares traded. Analysts at Roth Capital have recently initiated coverage on the company with a “buy” rating and a price target of $52.00. Shares of Sarepta Therapeutics have gained approximately 60.0 percent year-to-date. Going forward ... (see research report)

News & Events SRPT